BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15818083)

  • 1. Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flow.
    Rakhit RD; Seiler C; Wustmann K; Zbinden S; Windecker S; Meier B; Eberli FR
    Coron Artery Dis; 2005 May; 16(3):147-52. PubMed ID: 15818083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of tumor necrosis factor (TNF-alpha) and interleukin 6 (IL-6) in serum of patients with acute myocardial infarction].
    Halawa B; Salomon P; Jołda-Mydłowska B; Zyśko D
    Pol Arch Med Wewn; 1999 Mar; 101(3):197-203. PubMed ID: 10697395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction.
    Lee CW; Park SW; Cho GY; Hong MK; Kim JJ; Kang DH; Song JK; Lee HJ; Park SJ
    J Am Coll Cardiol; 2000 Mar; 35(4):949-55. PubMed ID: 10732893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction.
    Noda T; Minatoguchi S; Fujii K; Hori M; Ito T; Kanmatsuse K; Matsuzaki M; Miura T; Nonogi H; Tada M; Tanaka M; Fujiwara H
    J Am Coll Cardiol; 1999 Dec; 34(7):1966-74. PubMed ID: 10588211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.
    Halkin A; Stone GW; Grines CL; Cox DA; Rutherford BD; Esente P; Meils CM; Albertsson P; Farah A; Tcheng JE; Lansky AJ; Mehran R
    J Am Coll Cardiol; 2006 Mar; 47(5):951-61. PubMed ID: 16516077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation.
    Puhakka M; Magga J; Hietakorpi S; Penttilä I; Uusimaa P; Risteli J; Peuhkurinen K
    J Card Fail; 2003 Aug; 9(4):325-32. PubMed ID: 13680554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral pressure and flow in acute myocardial infarction with total coronary occlusion correlate with angiographic collateral grade and creatine kinase levels.
    Meisel SR; Shochat M; Frimerman A; Asif A; Blondheim DS; Shani J; Rozenman Y; Shotan A
    Am Heart J; 2010 May; 159(5):764-71. PubMed ID: 20435184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction.
    Ohtsuka T; Hamada M; Inoue K; Ohshima K; Sujzuki J; Matsunaka T; Ogimoto A; Hara Y; Shigematsu Y; Higaki J
    Clin Cardiol; 2004 Jul; 27(7):417-20. PubMed ID: 15298045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early peak creatine kinase activity is not always a marker of successful reperfusion with myocardial salvage in patients with reperfused anterior acute myocardial infarction.
    Kosuge M; Kimura K; Ishikawa T; Endo T; Shimizu M; Hongo Y; Okuda J; Tochikubo O; Umemura S
    Am Heart J; 2001 May; 141(5):759-64. PubMed ID: 11320363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index.
    Ortiz-Pérez JT; Lee DC; Meyers SN; Davidson CJ; Bonow RO; Wu E
    JACC Cardiovasc Imaging; 2010 May; 3(5):491-500. PubMed ID: 20466344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction.
    Sorajja P; Gersh BJ; Mehran R; Lansky AJ; Krucoff MW; Webb J; Cox DA; Brodie BR; Stone GW
    Am Heart J; 2007 Aug; 154(2):379-84. PubMed ID: 17643592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.
    Patti G; Mega S; Pasceri V; Nusca A; Giorgi G; Zardi EM; D'Ambrosio A; Dobrina A; Di Sciascio G
    Clin Cardiol; 2005 Apr; 28(4):193-6. PubMed ID: 15869054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
    Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K
    Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention.
    Namiuchi S; Kagaya Y; Ohta J; Shiba N; Sugi M; Oikawa M; Kunii H; Yamao H; Komatsu N; Yui M; Tada H; Sakuma M; Watanabe J; Ichihara T; Shirato K
    J Am Coll Cardiol; 2005 May; 45(9):1406-12. PubMed ID: 15862410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty.
    Youssef AA; Chang LT; Hang CL; Wu CJ; Cheng CI; Yang CH; Sheu JJ; Chai HT; Chua S; Yeh KH; Yip HK
    Circ J; 2007 May; 71(5):703-8. PubMed ID: 17456995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion.
    Matetzky S; Freimark D; Chouraqui P; Novikov I; Agranat O; Rabinowitz B; Kaplinsky E; Hod H
    J Am Coll Cardiol; 1998 Nov; 32(5):1326-30. PubMed ID: 9809943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
    Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.